← Back to Search

Behavioural Intervention

Experimental group for Type 2 Diabetes

Phase 2

Waitlist Available

Led By Mary O Whipple, PhD, RN, PHN

Research Sponsored by University of Minnesota

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged 55 years and older

Self-reported diagnosis of T2D

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 7 days

Awards & highlights

Study Summary

This trial focuses on the higher risk of Type 2 Diabetes faced by Black individuals and how their lack of physical activity contributes to this risk. The study aims to understand the impact of sedentary behavior

Who is the study for?

This trial is for Black older adults with Type 2 Diabetes who are interested in reducing sedentary behavior to potentially improve their cardiovascular health. The study aims to understand and develop strategies tailored to this group's unique experiences and challenges.Check my eligibility

What is being tested?

The study is testing personalized strategies designed collaboratively with participants to break up long periods of sitting or lying down, which can be harmful to health. It focuses on the relationship between sedentary behavior and various personal and societal factors.See study design

What are the potential side effects?

Since the intervention involves lifestyle changes rather than medication, side effects are not typical as seen in drug trials. However, increasing physical activity after being sedentary could result in muscle soreness or fatigue.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 55 years old or older.

Select...

I have been diagnosed with type 2 diabetes.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 7 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~7 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

sedentary time

Trial Design

1Treatment groups

Experimental Treatment

Group I: Experimental groupExperimental Treatment1 Intervention

Black adults aged 55 and older with T2D

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor

1,381 Previous Clinical Trials

1,588,945 Total Patients Enrolled

Mary O Whipple, PhD, RN, PHNPrincipal InvestigatorUniversity of Minnesota

1 Previous Clinical Trials

80 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the safety considerations for individuals in the experimental cohort?

"Based on the classification of this trial as a Phase 2 study, our team at Power rates the safety profile of the Experimental group as a 2. This indicates that while there is existing data supporting safety measures, efficacy outcomes are yet to be determined."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Collaborative Solutions for Breaking up Sedentary Time in Black Older Adults With Type 2 Diabetes: The Interrupt Diabetes Study

2024. "Collaborative Solutions for Breaking up Sedentary Time in Black Older Adults With Type 2 Diabetes: The Interrupt Diabetes Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06283849.